Trial site
BRCR Medical Center Inc
- 12running trials
- 7closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Colorectal cancer2 trials
- Follicular lymphoma2 trials
- Gastric and oesophageal cancer2 trials
- Metastatic breast cancer2 trials
- Brain metastases1 trial
- Childhood cancers1 trial
- Crohn's disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Liver and biliary tract cancer1 trial
- Multiple myeloma1 trial
- and 4 more
- Phase
- Phase 312 trials
- Phase 23 trials
- Phase 12 trials
- Phase 1/22 trials
- Status
- Active, not recruiting10 trials
- Completed6 trials
- Recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- Pfizer3 trials
- Enliven Therapeutics2 trials
- NovoCure GmbH2 trials
- Dizal Pharmaceuticals1 trial
- DualityBio Inc.1 trial
- and 10 more
Running trials
Recruiting
Active, not recruiting
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
Recruiting
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Recruiting
Completed
Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026